Page last updated: 2024-10-31

neostigmine and Spinal Diseases

neostigmine has been researched along with Spinal Diseases in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Spinal Diseases: Diseases involving the SPINE.

Research Excerpts

ExcerptRelevanceReference
"The authors report a case of Ogilvie's syndrome following spinal deformity correction and tethered cord release in an adolescent who presented with acute abdominal distension, nausea, and vomiting on postoperative Day 0."1.40Ogilvie's syndrome after pediatric spinal deformity surgery: successful treatment with neostigmine. ( Hooten, KG; Larson, SD; Oliveria, SF; Pincus, DW, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hooten, KG1
Oliveria, SF1
Larson, SD1
Pincus, DW1
Althausen, PL1
Gupta, MC1
Benson, DR1
Jones, DA1

Trials

1 trial available for neostigmine and Spinal Diseases

ArticleYear
The use of neostigmine to treat postoperative ileus in orthopedic spinal patients.
    Journal of spinal disorders, 2001, Volume: 14, Issue:6

    Topics: Adolescent; Adult; Female; Humans; Intestinal Obstruction; Male; Middle Aged; Neostigmine; Orthopedi

2001

Other Studies

1 other study available for neostigmine and Spinal Diseases

ArticleYear
Ogilvie's syndrome after pediatric spinal deformity surgery: successful treatment with neostigmine.
    Journal of neurosurgery. Pediatrics, 2014, Volume: 14, Issue:3

    Topics: Adolescent; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Female; Humans; Injections, Intra

2014